172 related articles for article (PubMed ID: 3130977)
21. [Sterility, Stein and H.M.G: a case report].
Costes D
Bull Fed Soc Gynecol Obstet Lang Fr; 1969; 21(5):519-20. PubMed ID: 5386395
[No Abstract] [Full Text] [Related]
22. [Treatment options of clomiphene-resistant polycystic ovary syndrome related infertility].
Liang X; Zhuang G; Zhou C
Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):591-3. PubMed ID: 11372407
[TBL] [Abstract][Full Text] [Related]
23. Possible metformin effect on adrenal androgens during pretreatment and IVF cycle in women with polycystic ovary syndrome.
Kjøtrød SB; Sunde A; von Düring V; Carlsen SM
Fertil Steril; 2009 Feb; 91(2):500-8. PubMed ID: 18304542
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of polycystic ovary syndrome and related infertility with clomiphene resistance by compound cyproterone acetate].
Tao Y; Dai Q; Zhang D
Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):528-32. PubMed ID: 11360636
[TBL] [Abstract][Full Text] [Related]
25. [Clinical analysis of 4 treatments for woman polycystic ovarian syndrome with infertility].
Shi XB; Zhou LY; Fu SX; Chen JL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):359-62. PubMed ID: 16859124
[TBL] [Abstract][Full Text] [Related]
26. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
[TBL] [Abstract][Full Text] [Related]
27. [Effects of metformin on gonadotropin-induced ovulation in patients with polycystic ovary syndrome].
Zhao JZ; Ye BL; Lin JJ; Lin WQ; Chi HH
Zhonghua Fu Chan Ke Za Zhi; 2003 Sep; 38(9):545-8. PubMed ID: 14680609
[TBL] [Abstract][Full Text] [Related]
28. [Ovulation induction in sterile females with the polycystic ovary syndrome].
Palatyński A; Majak J
Zentralbl Gynakol; 1985; 107(4):208-12. PubMed ID: 3157285
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a new surgical approach for the treatment of clomiphene citrate-resistant infertility in polycystic ovary syndrome: laparoscopic ovarian multi-needle intervention.
Kaya H; Sezik M; Ozkaya O
J Minim Invasive Gynecol; 2005; 12(4):355-8. PubMed ID: 16036198
[TBL] [Abstract][Full Text] [Related]
30. Reduction of dehydroepiandrosterone sulfate synthesis in women with polycystic ovary syndrome by human menopausal gonadotropin but not purified urinary follicle stimulating hormone: a comparative pilot study.
Turkmen S; Backstrom T; Idil M
Gynecol Endocrinol; 2004 Aug; 19(2):69-78. PubMed ID: 15624268
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic strategies for ovulation induction in infertile women with polycystic ovary syndrome.
Cristello F; Cela V; Artini PG; Genazzani AR
Gynecol Endocrinol; 2005 Dec; 21(6):340-52. PubMed ID: 16390783
[TBL] [Abstract][Full Text] [Related]
32. [Efficacy and endocrinological analysis of combined buserelin-pure FSH-hCG therapy in patients with polycystic ovary syndrome].
Ohkura T; Watabe H; Horinaka T; Segawa Y; Hayashi M; Yaoi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1994 Oct; 46(10):1013-9. PubMed ID: 7814930
[TBL] [Abstract][Full Text] [Related]
33. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation.
Mitwally MF; Casper RF
J Soc Gynecol Investig; 2004 Sep; 11(6):406-15. PubMed ID: 15350255
[TBL] [Abstract][Full Text] [Related]
34. Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome.
van Wely M; Fauser BC; Laven JS; Eijkemans MJ; van der Veen F
Fertil Steril; 2006 Dec; 86(6):1710-5. PubMed ID: 17022982
[TBL] [Abstract][Full Text] [Related]
35. [Congression and regression tree analyses on the outcome of ovulation induction in women with polycystic ovary syndrome].
Wang Y; Li M; Zhao Y
Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):594-6. PubMed ID: 11372408
[TBL] [Abstract][Full Text] [Related]
36. Proper selection of patients for intermediate-dose pure follicle stimulating hormone.
Kim JH; Richards CJ; Seibel MM
J Reprod Med; 1994 Jan; 39(1):1-5. PubMed ID: 8169907
[TBL] [Abstract][Full Text] [Related]
37. Treatment of polycystic ovary disease with chronic low-dose follicle stimulating hormone: biochemical changes and ultrasound correlation.
Seibel MM; Kamrava MM; McArdle C; Taymor ML
Int J Fertil; 1984; 29(1):39-43. PubMed ID: 6146583
[TBL] [Abstract][Full Text] [Related]
38. Comparison between human urinary follicle-stimulating hormone and human menopausal gonadotropin treatment in polycystic ovary.
Venturoli S; Paradisi R; Fabbri R; Magrini O; Porcu E; Flamigni C
Obstet Gynecol; 1984 Jan; 63(1):6-11. PubMed ID: 6419189
[TBL] [Abstract][Full Text] [Related]
39. Ovulation induction: a mini review.
Messinis IE
Hum Reprod; 2005 Oct; 20(10):2688-97. PubMed ID: 16006478
[TBL] [Abstract][Full Text] [Related]
40. Induction of ovulation with purified urinary follicle-stimulating hormone in patients with polycystic ovarian syndrome.
Garcea N; Campo S; Panetta V; Venneri M; Siccardi P; Dargenio R; De Tomasi F
Am J Obstet Gynecol; 1985 Mar; 151(5):635-40. PubMed ID: 3919586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
